ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.027,59
-0,38%
S&P 500
5.308,15
1,17%
US Dollar vs BRL
5,1362
0,02%
Bitcoin
66.154,12
-0,16%
Brent Oil
82,815
0,19%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Omeros Corporation (OMER)

  7. Omeros Corporation (OMER) Notícias

OMER

Omeros (OMER)

Omeros Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:OMER
DataHoraFonteTítuloCódigoCompanhia
15/05/202417:09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OMEROmeros Corporation
15/05/202417:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMEROmeros Corporation
15/05/202417:02Business WireOmeros Corporation Reports First Quarter 2024 Financial ResultsNASDAQ:OMEROmeros Corporation
10/05/202409:50Business WireOmeros Corporation to Announce First Quarter Financial Results on May 15, 2024NASDAQ:OMEROmeros Corporation
09/05/202409:50Business WireOmeros Corporation Announces Upcoming Presentations at 2024 European Hematology Association (EHA) Hybrid CongressNASDAQ:OMEROmeros Corporation
01/04/202417:02Business WireOmeros Corporation Reports Fourth Quarter and Year-End 2023 Financial ResultsNASDAQ:OMEROmeros Corporation
27/03/202409:30Business WireOmeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024NASDAQ:OMEROmeros Corporation
20/02/202411:00Business WireOmeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic MicroangiopathyNASDAQ:OMEROmeros Corporation
14/02/202408:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OMEROmeros Corporation
01/02/202411:11Business WireOmeros Corporation Announces Additional Royalty Monetization with DRI Healthcare TrustNASDAQ:OMEROmeros Corporation
29/01/202417:26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:OMEROmeros Corporation
21/11/202322:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
09/11/202318:02Business WireOmeros Corporation Reports Third Quarter 2023 Financial ResultsNASDAQ:OMEROmeros Corporation
06/11/202310:00Business WireOmeros Corporation to Announce Third Quarter Financial Results on November 9, 2023NASDAQ:OMEROmeros Corporation
03/11/202310:05Business WireOmeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic MicroangiopathyNASDAQ:OMEROmeros Corporation
02/11/202310:05Business WireOmeros Corporation Announces Upcoming Presentations at ASH Annual MeetingNASDAQ:OMEROmeros Corporation
19/10/202309:30Business WireOmeros Corporation Hires Andreas Grauer M.D. as Chief Medical OfficerNASDAQ:OMEROmeros Corporation
16/10/202308:30Business WireOmeros Corporation Provides Update on Interim Analysis of ARTEMIS-IGAN Phase 3 Trial of Narsoplimab in IgA NephropathyNASDAQ:OMEROmeros Corporation
20/09/202317:47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OMEROmeros Corporation
09/08/202318:20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:OMEROmeros Corporation
09/08/202309:00Business WireOmeros Corporation Reports Second Quarter 2023 Financial ResultsNASDAQ:OMEROmeros Corporation
04/08/202309:00Business WireOmeros Corporation to Announce Second Quarter Financial Results on Morning of August 9, 2023NASDAQ:OMEROmeros Corporation
27/06/202320:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OMEROmeros Corporation
21/06/202309:30Business WireOmeros Announces Webcast Details for Annual Meeting of ShareholdersNASDAQ:OMEROmeros Corporation
12/06/202309:45Business WireOmeros Corporation Announces Availability on Its Website of Materials Accompanying Presentations of OMS906 Data at the 2023 European Hematology Association CongressNASDAQ:OMEROmeros Corporation
01/06/202312:00Business WireOmeros Corporation Announces Late-Breaking Presentation of OMS906 Data at the 2023 European Hematology Association (EHA) CongressNASDAQ:OMEROmeros Corporation
22/05/202318:42Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:OMEROmeros Corporation
17/05/202318:07Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:OMEROmeros Corporation
17/05/202317:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OMEROmeros Corporation
16/05/202319:33Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OMEROmeros Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:OMER

Seu Histórico Recente

USOTC
FRPC
First Rep Corp America (CE)
LSE
ZR82
Citi Fun 24
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados